Madrigal Pharmaceuticals Inc (MDGL)

Free Cash Flow

$116.63M

Quarterly · Period ending: · USD

MDGL logo

MDGL Free Cash Flow

Latest reported$116.63M
MDGL Quarterly Free Cash Flow (-$14.20M → $116.63M)
High-resolution chart · PNG

MDGL free cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Free Cash Flow — Quarterly (USD)
Period endingFree Cash Flow (USD)
116,628,000
19,076,000
-171,284,000
-133,070,000
78,993,000
-47,052,000
-88,891,000
-104,681,000
-67,763,000
-140,076,000
-149,514,000
-80,969,000
-85,259,000
-75,379,000
-84,102,000
-58,544,000
-59,102,000
-57,463,000
-49,965,000
-48,164,000
-45,606,000
-46,883,000
-43,473,000
-54,957,000
-47,853,000
-24,265,000
-30,820,000
-12,416,000
-11,322,000
-11,539,000
-6,519,000
-6,273,000
-5,251,000
-5,360,000
-8,645,000
-5,820,000
-4,951,000
-7,773,000
-3,773,000
-5,281,637
6,954,937
-7,070,000
-12,214,000
-19,355,000
-15,615,000
-17,757,000
-18,775,000
-19,274,000
-18,603,000
-20,899,000
-20,293,000
-18,772,000
-16,604,000
-20,314,000
-22,490,000
-12,607,000
-13,472,000
-13,160,000
-15,401,000
-10,868,000
-12,084,000
-12,189,000
-12,849,000
-8,239,000
-8,495,000
-9,012,000
-12,589,000
-7,205,000
-8,281,000
-23,622,000
11,844,000
15,803,000
-20,274,000
-19,537,000
-16,115,000
67,507,000
-16,066,000
-12,898,000
-13,671,000
-11,702,000
-14,197,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.